Table 1.
Age | Gender | Total | Type of NSCLC | Stage | SCLC | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||
M | W | amount | % | LCC | SCC | AC | not defined | I | II | III | IV | LD | ED | |
20–24 | 1 | 2 | 3 | 7 | 0 | 0 | 1 | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
25–29 | 3 | 1 | 4 | 10 | 0 | 1 | 1 | 1 | 0 | 0 | 3 | 0 | 1 | 0 |
30–34 | 2 | 3 | 5 | 12 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 1 |
35–39 | 17 | 13 | 30 | 71 | 1 | 3 | 10 | 9 | 2 | 0 | 6 | 15 | 2 | 5 |
Total | 23 | 19 | 42 | 100 | 1 | 4 | 14 | 13 | 5 | 0 | 10 | 17 | 4 | 6 |
LCC – large cell carcinoma, SCC – squamous cell carcinoma, AC – adenocarcinoma, LD – limited disease, ED – extensive disease